Active Pharmaceutical Ingredient (API)
Belimumab
B-cell Inhibitor (SLE)
A human monoclonal antibody that inhibits B-lymphocyte stimulator ($\text{BLyS}$). By preventing BLyS from binding to B-cells, it promotes B-cell apoptosis and reduces autoantibody production in Systemic Lupus Erythematosus ($\text{SLE}$).
Technical Profile
- Reference Code
- BEL710
- CAS Number
- 356547-88-1
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Belimumab as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||